19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is PLERIXAFOR, with a corresponding application number 22311 and regulatory information .
proudly manufactured in the
approval since 2008-12-15
Sanofi's MOZOBIL SOLUTION;SUBCUTANEOUS, medication with 24MG/1.2ML (20MG/ML) of PLERIXAFOR.